1. Home
  2. CFFN vs STOK Comparison

CFFN vs STOK Comparison

Compare CFFN & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFFN
  • STOK
  • Stock Information
  • Founded
  • CFFN 1893
  • STOK 2014
  • Country
  • CFFN United States
  • STOK United States
  • Employees
  • CFFN N/A
  • STOK N/A
  • Industry
  • CFFN Savings Institutions
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CFFN Finance
  • STOK Health Care
  • Exchange
  • CFFN Nasdaq
  • STOK Nasdaq
  • Market Cap
  • CFFN 777.8M
  • STOK 721.4M
  • IPO Year
  • CFFN 1999
  • STOK 2019
  • Fundamental
  • Price
  • CFFN $6.89
  • STOK $11.43
  • Analyst Decision
  • CFFN Hold
  • STOK Strong Buy
  • Analyst Count
  • CFFN 2
  • STOK 7
  • Target Price
  • CFFN $6.75
  • STOK $21.40
  • AVG Volume (30 Days)
  • CFFN 696.9K
  • STOK 470.9K
  • Earning Date
  • CFFN 10-23-2024
  • STOK 11-05-2024
  • Dividend Yield
  • CFFN 4.93%
  • STOK N/A
  • EPS Growth
  • CFFN N/A
  • STOK N/A
  • EPS
  • CFFN 0.29
  • STOK N/A
  • Revenue
  • CFFN $166,046,000.00
  • STOK $16,742,999.00
  • Revenue This Year
  • CFFN N/A
  • STOK $91.67
  • Revenue Next Year
  • CFFN $9.30
  • STOK $5.45
  • P/E Ratio
  • CFFN $23.76
  • STOK N/A
  • Revenue Growth
  • CFFN N/A
  • STOK 81.08
  • 52 Week Low
  • CFFN $4.76
  • STOK $3.77
  • 52 Week High
  • CFFN $7.20
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • CFFN 60.15
  • STOK 36.03
  • Support Level
  • CFFN $6.52
  • STOK $11.08
  • Resistance Level
  • CFFN $6.92
  • STOK $11.73
  • Average True Range (ATR)
  • CFFN 0.19
  • STOK 0.73
  • MACD
  • CFFN -0.04
  • STOK -0.23
  • Stochastic Oscillator
  • CFFN 65.56
  • STOK 9.62

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

Share on Social Networks: